Category Archives: 2013

Highlights of 2013; New Urine Test for Prostate Cancer.

A new urine test for prostate cancer that measures minute fragments of ribonucleic acid (RNA) is now commercially available nationwide through the University of Michigan MLabs. The new test [Mi-Prostate Score (MiPS)], improves the utility of the PSA blood test, more »

Posted in 2013, Diagnostics, Genetics, Imaging | Leave a comment

Christmas-New Year 2013 Greeting

First and foremost, as we are nearing the end of 2013, I wish to thank the nearly 200,000 readers of this website. Writing it is a joy for me personally, and it was especially gratifying to receive comments from prostate cancer more »

Posted in 2013, Encouragement | Leave a comment

Targeted Delivery of Cancer Drugs Such as Docetaxel (Taxotere).

An August 11th, 2013 blog (below) on this website described how a chemotherapeutic drug such as docetaxel (taxotere) used in the treatment of advanced prostate cancer could be administered more effectively and with less side effects. Taxotere is a variant more »

Posted in 2013, Treatment Information | 1 Comment

In a Test of my Faith, I Received a Grade of C(-). I Passed but Could Do Better.

During my personal and scientific career, I have been blessed to meet and interact with some extremely interesting and gifted people. One such person, Dr. Raymond Damadian, is the inventor of magnetic resonance (MR) scanning. He and I formerly attended the same church in Long more »

Posted in 2013, Encouragement | Leave a comment

Neuroendocrine Prostate Cancer; a Lethal Result of Resistance to Hormone Therapy.

Most (90%) of all prostate cancers are initially diagnosed as treatable adenocarcinoma. However, every adenocarcinoma type of cancer contains a sub-type of cells (often 1% or less) called neuroendocrine  prostate cancer (NEPC) cells. While adenocarcinoma cells often metastasize to bone, NEPC more »

Posted in 2013, Treatment Information | 1 Comment

Nerve-Sparing Radical Prostatectomy

Surgery (radical prostatectomy) is one option for treating prostate cancer. Personally, since I was in my mid-50’s when prostate cancer was detected, I opted for this route. The two major risks posed by surgery and other treatments are incontinence and impotence.  The area more »

Posted in 2013, Treatment Information | Leave a comment

A New Urine Test for Prostate Cancer Combining Genetic Biomarkers.

Considerable academic and commercial research efforts are underway in order to identify and utilize genetic biomarkers to aid in the diagnosis and characterization of prostate cancers, to determine their aggressiveness, to ascertain the need for biopsies, and to monitor therapeutic regimens. more »

Posted in 2013, Diagnostics, Genetics, Imaging | 1 Comment

Measuring PSA Activity May Be a Better Predictor of Prostate Cancer Aggressiveness.

Research results recently published online in the August 9th issue of The Prostate (Prostate 2013, DOI:10.1002/pros.22714) suggest that measuring the biological enzymatic activity (or lack thereof) of prostate-specific antigen (PSA) could be used as a predictor of prostate cancer (PCa) more »

Posted in 2013, Diagnostics, Genetics, Imaging, General Patient Information | Leave a comment

Johns Hopkins Urology: A Valuable Resource for Prostate Cancer Information.

The Department of Urology at the Johns Hopkins Hospital in Baltimore, Maryland has consistently been rated best (#1) in the annual survey published in U.S. News and World Report. Hopkins urologists provide an excellent source of prostate information via a number of publications. Recent more »

Posted in 2013, General Patient Information | 1 Comment

Jesus, the Healer; Does He Promise to Heal?

In Matthew 14:14, Jesus saw a great multitude of people, had compassion on them and healed their sick. The Great Physician is able to heal. He created us and knows every mechanism in our body down to the most minute more »

Posted in 2013, Encouragement | 1 Comment